273 related articles for article (PubMed ID: 8960822)
1. Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture.
Pandolfi A; Iacoviello L; Capani F; Vitacolonna E; Donati MB; Consoli A
Diabetologia; 1996 Dec; 39(12):1425-31. PubMed ID: 8960822
[TBL] [Abstract][Full Text] [Related]
2. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis.
Nordt TK; Klassen KJ; Schneider DJ; Sobel BE
Arterioscler Thromb; 1993 Dec; 13(12):1822-8. PubMed ID: 8241103
[TBL] [Abstract][Full Text] [Related]
4. Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary artery.
Zhang WJ; Wojta J; Binder BR
Cell Mol Biol (Noisy-le-grand); 1997 Jun; 43(4):581-7. PubMed ID: 9220151
[TBL] [Abstract][Full Text] [Related]
5. Pathogenetic implications of hyaluronan-induced modification of vascular smooth muscle cell fibrinolysis in diabetes.
Marutsuka K; Woodcock-Mitchell J; Sakamoto T; Sobel BE; Fujii S
Coron Artery Dis; 1998; 9(4):177-84. PubMed ID: 9649923
[TBL] [Abstract][Full Text] [Related]
6. Effects of cadmium on the release of tissue plasminogen activator and plasminogen activator inhibitor type 1 from cultured human vascular smooth muscle cells and fibroblasts.
Yamamoto C; Kaji T; Sakamoto M; Kozuka H
Toxicology; 1996 Jan; 106(1-3):179-85. PubMed ID: 8571389
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
[TBL] [Abstract][Full Text] [Related]
8. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
[TBL] [Abstract][Full Text] [Related]
9. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
10. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
[TBL] [Abstract][Full Text] [Related]
11. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells.
Hu XY; Ma YH; Wang C; Yang YH
Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering.
Haslinger B; Goedde MF; Toet KH; Kooistra T
Kidney Int; 2002 Nov; 62(5):1611-9. PubMed ID: 12371961
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose.
Maiello M; Boeri D; Podesta F; Cagliero E; Vichi M; Odetti P; Adezati L; Lorenzi M
Diabetes; 1992 Aug; 41(8):1009-15. PubMed ID: 1628760
[TBL] [Abstract][Full Text] [Related]
14. Losartan inhibits the angiotensin II-induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells.
Papakonstantinou E; Roth M; Kokkas B; Papadopoulos C; Karakiulakis G
J Cardiovasc Pharmacol; 2001 Nov; 38(5):715-28. PubMed ID: 11602818
[TBL] [Abstract][Full Text] [Related]
15. Impact of lysophosphatidylcholine on the plasminogen activator system in cultured vascular smooth muscle cells.
Yoon BK; Kang YH; Oh WJ; Park K; Lee DY; Choi D; Kim DK; Lee Y; Rhyu MR
J Korean Med Sci; 2012 Jul; 27(7):803-10. PubMed ID: 22787379
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.
Zhang WJ; Wojta J; Binder BR
J Vasc Res; 1997; 34(4):273-80. PubMed ID: 9256087
[TBL] [Abstract][Full Text] [Related]
17. Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells.
Zhang J; Ren S; Shen GX
Atherosclerosis; 2000 Jun; 150(2):299-308. PubMed ID: 10856522
[TBL] [Abstract][Full Text] [Related]
18. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells.
Ekhterae D; Stanley JC
J Vasc Surg; 1995 Jun; 21(6):953-62. PubMed ID: 7776475
[TBL] [Abstract][Full Text] [Related]
19. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
Orbe J; Chordá C; Montes R; Páramo JA
Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
Nakashima A; Kobayashi T; Terao T
Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
